Clinical Trial Update: A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating MD-7246 for abdominal pain in diarrhea-predominant irritable bowel syndrome (IBS-D) has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Diarrhea

Drugs mentioned

• MD-7246

Snippet

Sponsor: Ironwood Pharmaceuticals, Inc. | Conditions: Irritable Bowel Syndrome With Diarrhea (IBS-D) | Phase 2 | Status: COMPLETED | Results posted: 2021-03-12